News Articles
A scientific hub to keep you informed about our latest research and company updates.
InnoSer, Connected-Pathology, and Poulpharm Announce Strategic Partnership to Expand Preclinical and Histopathology Services
InnoSer and CureSHANK partner to launch industry-quality preclinical testing service for Phelan-McDermid syndrome (PMS) treatments
InnoSer Partners with Kabuki Syndrome Foundation to Advance Therapeutic Development for Kabuki Syndrome
Top 4 Multi-Organ-on-a-Chip TissUse Assays and Why You Should Include them in Your Preclinical Research in 2025
InnoSer Strengthens Neurology Platform with Acquisition of remynd’s CRO Business
InnoSer International Announces Leadership Transition: Kris Motmans Appointed as New CEO
Project Completion Announcement: CARDIOIDS Collaboration with Professor Leon de Windt Advances Arrhythmogenic Cardiomyopathy (ACM) Research
InnoSer and TissUse Sign Strategic Co-Marketing Agreement to Advance Microphysiological Systems (MPS) Applications in Drug Development
InnoSer completes a major milestone in the HEAL project with validated tumorigenicity assay
InnoSer Announces Joint Initiative with Hasselt University/BIOMED to Support Preclinical Multiple Sclerosis Research
InnoSer partners with CR2O to offer an integrated drug discovery to clinical trials pipeline.
info@innoserlaboratories.com